Related Experiment Video

Updated: Mar 28, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.3K

Development of an algorithm to assess appropriateness of overriding alerts for nonformulary medications in a

Qoua L Her1, Diane L Seger2, Mary G Amato2

  • 1Qoua L. Her, Pharm.D., M.S., M.Sc., is Pharmacy Informatics and Outcomes Research Fellow, MCPHS University School of Pharmacy-Boston and Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital (BWH), Boston, MA. Diane L. Seger, B.S.Pharm., is Senior Pharmaco-Informatics Specialist, Clinical and Quality Analysis, Information Systems, Partners HealthCare System, Inc., Wellesley, MA. Mary G. Amato, Pharm.D., M.P.H., is Associate Professor of Pharmacy Practice, MCPHS University, Boston. Patrick E. Beeler, M.D., is Postdoctoral Research Fellow, Division of General Internal Medicine and Primary Care, BWH, and Research Fellow, Harvard Medical School, Boston. Olivia Dalleur, M.Pharm., Ph.D., is Research Associate in Medicine, Division of General Internal Medicine and Primary Care, BWH, and Assistant Professor in Clinical Pharmacy, Louvain Drug Research Institute, Clinical Pharmacy Research Group, Cliniques, Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium. Sarah P. Slight, M.Pharm., Ph.D., P.G.Dip., is Senior Lecturer/Associate Professor of Pharmacy Practice, Wolfson Research Institute, School of Medicine, Pharmacy and Health, Durham University, Queen's Campus, Stockton-on-Tees, England, and Visiting Research Scholar, Division of General Internal Medicine and Primary Care, BWH. Patricia C. Dykes, Ph.D., RN, FACMI, is Program Director, Center for Patient Safety, Research and Practice, BWH. David W. Bates, M.D., M.Sc., is Senior Vice President for Quality and Safety and Chief Quality Officer, Division of General Internal Medicine and Primary Care, BWH. qher@partners.org.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|December 20, 2015
PubMed
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.5K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

31.5K

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.7K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
347
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
300
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
460